Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.

Swaths of SoCal face heat-related advisories and forecasted record-breaking temperatures. It doesn't take much to dry out ...

Each year, the Asthma and Allergy Foundation of America ranks the largest 100 cities in the lower 48 states by how challenging they are to live in when you have ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...

A warm and dry winter is hammering Colorado ski town businesses during what is typically their busiest month. Some ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter to Aldeyra Therapeutics for its New Drug Application of reproxalap for the treatment of dry eye dis ...

FDA rejection was attributed to a lack of substantial evidence of efficacy, including inconsistencies that undermined confidence in reproducibility across investigations. Reproxalap targets reactive ...

Even in an era of remarkable therapeutics for neovascular age-related macular degeneration, there remains a lack of therapies to improve vision in dry AMD. Many patients continue to live with central ...

Alcon demonstrates potential resilience vs. market shocks, with favorable balance sheet risk and positive EPS forecasts for FY26. Read why ALC stock is a Buy.

I was asked for a short presentation for folks who have not yet learned about global warming. I thought it might help to share the presentation here to get us […] ...